Our 15 most popular stories covering new research and data highlight the major trends reshaping the industry When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Every year, designers at Pew Research Center create hundreds of charts, maps and other data visualizations. We also help make a range of other digital products, from “scrollytelling” features to ...

Canton has claimed the title of Georgia’s biggest boomtown, according to new research that examined nearly a decade of growth across the country. The city stood out among communities of similar size, ...

Brookfield Corporation sees a once-in-a-generation opportunity to invest in building infrastructure to support AI. The global investment firm and its affiliates are investing heavily in the ...

Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build a standardized framework for ...

Stocks mostly rose Tuesday, as investors considered signs of labor-market weakness and a likely end to the government shutdown. The Dow Jones Industrial Average advanced 1.2% to a new record close.

Have you ever spent hours wrestling with messy spreadsheets, only to end up questioning your sanity over rogue spaces or mismatched text entries? If so, you’re not alone. Data cleaning is one of the ...

The scale and scope of federal data and statistics that have been completely removed or otherwise compromised by President Donald Trump’s administration is too overwhelming to chronicle fully. When ...

Payrolls at US companies unexpectedly dropped in September, according to ADP Research data released Wednesday. While part of that was due to an adjustment related to government numbers it relies on, ...

Google is turning its vast public data trove into a goldmine for AI with the debut of the Data Commons Model Context Protocol (MCP) Server — enabling developers, data scientists, and AI agents to ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...